注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Biophytis SA(原名:Institut Biophytis Sas),是一家法国医疗保健公司。该公司是一家生物技术实体,专门开发用于治疗衰老相关疾病的候选药物。它的两个产品涉及肌肉减少症(肌肉功能丧失)和年龄相关性黄斑变性(ARMD)。Biophytis SA同时在美国和国内市场从事其候选药物的临床和监管开发,如Sarconeos(BIO101)和Macuneos(BIO201)。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Nadine Coulm | 58 | 2015 | Independent Director |
Stanislas Veillet | 56 | 2015 | Chairman of the Board & CEO |
Rene Lafont | 76 | 2011 | Scientific Advisor & Member of Scientific Advisory Board |
Thomas Voit | - | 2017 | Member of Scientific Advisory Board |
Jose-Alain Sahel | - | - | Member of Scientific Advisory Board |
Jean Mariani | 74 | 2016 | Chairman of Scientific Advisory Board & Director |
Roger A. Fielding | - | 2016 | Member of Scientific Advisory Board |
Yann Meunier | - | 2023 | Member of Scientific Advisory Board |
Claude Allary | 68 | 2021 | Independent Director |
Bernard Levy | - | 2023 | Member of Scientific Advisory Board |
Francisco Guarner | - | 2024 | Member of Scientific Advisory Board |
Dennis Villareal | - | 2024 | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核